World Pharma News

More prescription ranitidine recalled from shelves

By Anna Smith The Medicines and Healthcare Regulatory Agency (MHRA) has issued a drug alert, as Creo Pharma Limited and Tillomed Laboratories have recalled their unexpired stock of prescription-only ranitidine. GSK’s formulation of the drug, called Zantac and used for heartburn and stomach ulcers, was recalled in the USA last month after the US Food and […]

Bayer and Roundup get more bad news Down Under

In the latest blow to Bayer, a farmer in Australia is suing the German pharmaceuticals company over its Roundup weedkiller, contending that it caused his leukemia. New South Wales farmer Ross Wild was diagnosed with Hodgkin’s Lymphoma last year after using Monsanto’s weed killer Roundup on his farm since 1976, the Australian Broadcasting Commission reported. Bayer bought St. […]

An important initiative on Olive oil and Health by two Greek professors at Yale University

By Maria Christina Baklava Two Greek professors at Yale University’s School of Public Health founded the Institute for Olive Science and Health, and organized the 1st Symposium on Olive Oil and Health, in 2018, with experts from many areas of the field in attendance. The 2nd Symposium on Olive Oil and Health will be held from December 1 […]

The 11 biopharma companies that declared bankruptcy this year

Editor’s note: This is part of a series about bankruptcy in the biopharma industry. Click here for the main piece, about how threats facing the industry could lead to more filings, and click here to see 31 biopharmas at high risk of bankruptcy for 2020. Eleven biopharmas have filed for bankruptcy so far this year, including Purdue Pharma, Achaogen and […]

Big Book of Clinical Trial Design

In recent years, the industry has seen clinical trials increase in complexity but decline in productivity. To improve clinical trial operations and increase the likelihood of regulatory approval, the industry needs to change its approach to clinical development. For this Big Book, we spoke to eight Pharma IQ community members, each responsible for a different stage […]

FDA should withdraw ANDAs’, and ‘new technologies could bring massive improvements in efficiency’ if implemented correctly

5 – 7 November 2019, Frankfurt, Germany. CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt – has released the first part of its eponymous 2019 Annual Report. Experts Bikash Chatterjee, President and Chief Science Officer at Pharmtech Associates and Girish Malhotra, President of EPCOT International discuss how manufacturing could be revolutionised by […]

Labour on collision course with big pharma over drugs

Hugh PymHealth editor@BBCHughPymon Twitter   Labour’s newly announced policy on research funding for new medicines raises big questions about the balance between private profit and public good. The party wants to make big drug companies hand over their exclusive research details so medicines can be made and sold more cheaply by others. Should major drug […]

Opioid Crisis Fast Facts

Prescription and illegal opioids are commonly abused because they are so addictive.    Opioid medications bind to the areas of the brain that control pain and emotions, driving up levels of the feel-good hormone dopamine in the brain’s reward areas and producing an intense feeling of euphoria.   As the brain becomes used to the […]

Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure

AstraZeneca today announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpoint with a statistically-significant and clinically-meaningful reduction of cardiovascular death or the worsening of heart failure (defined as hospitalisation or an urgent heart failure visit), compared to placebo. The trial was conducted in patients […]

Alexandre Joyeux: Erenumab reduces migraine costs in Germany

by Nicole Ntampou By €8.5 billion each year the German economy can potentially reduce losses in GDP, linked to the effects of migraines, he said, at the 13th Annual Conference of the European Association for Headaches, Dr. Alexandre Joyeux – Head, Global Patient Access Neurosciences at Novartis. The initial results show that, compared with the standard of […]